Treatment with Dapagliflozin followed by Spironolactone followed by their combination
( DrugBank: Spironolactone, Dapagliflozin / KEGG DRUG: Spironolactone, Dapagliflozin )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 218 | Alport syndrome | 1 |
218. Alport syndrome
Clinical trials : 47 / Drugs : 49 - (DrugBank : 23) / Drug target genes : 8 - Drug target pathways : 46
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
